BAT-7205

N/A

Report date: 2025/10/30 15:31:28

Base Information

Drug NameBAT-7205

Drug Alias NameBAT7205BAT-7205

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProgrammed death-ligand 1 antagonistsInterleukin-15 receptor subunit alpha agonists

TargetsProgrammed death-ligand 1Interleukin-15 receptor subunit alpha

Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesBio-Thera Solutions Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBio-Thera Solutions Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeoplasm Metastasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A